Mayo Clinic offers at-home colon cancer test

August 26, 2014 by Paul Walsh, Star Tribune (Minneapolis)

Mayo Clinic is taking another step toward making detection of colorectal cancer as convenient as possible, announcing Monday an at-home kit that arrives and is sent back in the mail, stool sample included.

In a joint announcement with Cologuard kit maker Exact Sciences of Madison, Wis., Mayo said the screening test will be available through its primary care doctors by prescription only.

Patients learn of their results in as little as two weeks from their doctor. A positive result prompts the need for a colonoscopy.

"Cologuard represents a significant advancement in identifying at its most treatable stage," Dr. Vijay Shah, chairman of gastroenterology and hepatology for Mayo, said in a statement accompanying the announcement. "We believe offering this new tool will promote patient and community public health and may move more patients to get screened earlier - a critical step in beating this prevalent and preventable cancer."

Cologuard was developed jointly by Mayo and Exact Sciences as the first - and so far, the only - noninvasive stool DNA screening test for colorectal cancer that has approval from the Food and Drug Administration.

The tests are meant for people 50 and older who are at average risk for colorectal cancer. Exact Science said it is the first noninvasive screening that analyzes both stool-based DNA and blood biomarkers to detect cancer and precancer.

With proper , colorectal cancer is highly preventable. However, 23 million Americans ages 50 to 75 are not getting screened as recommended, a factor in colorectal cancer remaining the second-leading cancer killer in the United States. Early detection can mean a five-year survival rate of more than 90 percent.

Dr. David Ahlquist, a Mayo gastroenterologist and co-inventor of the test, said, "I am hopeful that the test's efficacy and convenience will result in improved detection and survival rates for colorectal ."

Explore further: New test offers greater accuracy in early detection of colorectal cancer

Related Stories

Recommended for you

Oxygen can impair cancer immunotherapy in mice

August 25, 2016

Researchers have identified a mechanism in mice by which anticancer immune responses are inhibited within the lungs, a common site of metastasis for many cancers. This mechanism involves oxygen inhibition of the anticancer ...

Stem cell propagation fuels cancer risk in different organs

August 25, 2016

The idea that stem cells - special cells that divide to repair and generate tissues - might be the major determinant of cancer risk has provoked great debate in the scientific community. Some researchers maintain that environmental ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.